ARS PHARMACEUTICALS INC(SPRY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SPRY ARS PHARMACEUTICALS INC

Closed 07-10 16:00:00 EDT

7.94

+0.06

+0.76%

盘后7.94

+0.000.00%

19:39 EDT

High8.07	Low7.67	Vol1.40M
Open7.84	D1 Closing7.88	Amplitude5.08%
Mkt Cap784.86M	Tradable Cap337.04M	Total Shares98.85M
T/O11.05M	T/O Rate3.29%	Tradable Shares42.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":7.94,"timestamp":1783713600000,"preClose":7.88,"halted":0,"volume":1397535,"hourTrading":{"tag":"盘后","latestPrice":7.94,"preClose":7.94,"latestTime":"19:39 EDT","volume":1885,"amount":14962.88,"timestamp":1783726779594,"change":0,"changeRate":0,"amplitude":0.002519},"delay":0,"changeRate":0.007614213197969607,"floatShares":42448400,"shares":98848611,"eps":-2.004377,"marketStatus":"Closed","change":0.06,"latestTime":"07-10 16:00:00 EDT","open":7.84,"high":8.07,"low":7.67,"amount":11047157.803575,"amplitude":0.050761,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.004377,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783929600000},"marketStatusCode":5,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":7.88,"preHourTrading":{"tag":"盘前","latestPrice":7.87,"preClose":7.88,"latestTime":"09:29 EDT","volume":6085,"amount":48349.246174,"timestamp":1783690199999,"change":-0.01,"changeRate":-0.001269,"amplitude":0.149746},"postHourTrading":{"tag":"盘后","latestPrice":7.94,"preClose":7.94,"latestTime":"19:39 EDT","volume":1885,"amount":14962.88,"timestamp":1783726779594,"change":0,"changeRate":0,"amplitude":0.002519},"volumeRatio":0.950915,"impliedVol":1.4212,"impliedVolPercentile":0.8845},"requestUrl":"/m/hq/s/SPRY","defaultTab":"news","newsList":[{"id":"2649302549","title":"ARS Pharma Names President Donn Casale CEO, Replacing Co-founder Richard Lowenthal","url":"https://stock-news.laohu8.com/highlight/detail?id=2649302549","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649302549?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:30","pubTimestamp":1783456259,"startTime":"0","endTime":"0","summary":"ARS Pharma names President Donn Casale CEO, replacing co-founder Richard LowenthalARS Pharmaceuticals named President Donn Casale as CEO and director, effective July 7, 2026.Co-founder Richard Lowenth","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLbspn9l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930581","title":"ARS Pharmaceuticals - Richard Lowenthal to Step Down as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930581?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:30","pubTimestamp":1783456201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA2T2JNG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930309","title":"ARS Pharmaceuticals - Appoints Donn Casale as CEO and Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930309?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:30","pubTimestamp":1783456201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA2T2JNG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649193034","title":"Press Release: ARS Pharmaceuticals Announces CEO Succession","url":"https://stock-news.laohu8.com/highlight/detail?id=2649193034","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649193034?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:30","pubTimestamp":1783456200,"startTime":"0","endTime":"0","summary":"Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the CompanyDonn Casale, President, Appointed Chief Executive Officer and Director","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","SPRY","BK4139","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646389889","title":"ARS Pharma Shareholders Elect Directors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646389889","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646389889?lang=en_us&edition=fundamental","pubTime":"2026-06-26 05:01","pubTimestamp":1782421307,"startTime":"0","endTime":"0","summary":"ARS Pharma shareholders elect directors at annual meetingARS Pharmaceuticals held its annual shareholder meeting on June 24, 2026.Shareholders backed the appointment of Ernst & Young LLP as independen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL3l8hvh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646388296","title":"ARS Pharmaceuticals Down over 24%, on Track for Largest Percent Decrease Since September 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2646388296","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646388296?lang=en_us&edition=fundamental","pubTime":"2026-06-26 03:03","pubTimestamp":1782414180,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals, Inc.  is currently at $7.93, down $2.61 or 24.76%--Would be lowest close since May 20, 2026, when it closed at $7.80--On pace for largest percent decrease since Sept. 20, 2023, when it fell 55.79%--Snaps a three day winning streak--Down 12.57% month-to-date; on pace for worst month since March 2026, when it fell 13.47%--Down 31.93% year-to-date--Down 86.87% from its all-time closing high of $60.41 on March 17, 2021--Down 56.14% from 52 weeks ago , when it closed at $18.08--Down 56.78% from its 52-week closing high of $18.35 on July 28, 2025--Up 17.83% from its 52-week closing low of $6.73 on Nov. 20, 2025--Traded as low as $7.50; lowest intraday level since May 20, 2026, when it hit $7.19--Down 28.84% at today's intraday low; largest intraday percent decrease since Sept. 20, 2023, when it fell as much as 61.39%All data as of 3:01:34 PM ETSource: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 25, 2026 15:03 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646021748","title":"ARS Pharmaceuticals is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2646021748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646021748?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:25","pubTimestamp":1782404700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPRY/analyst-ratings(END) Dow Jones NewswiresJune 25, 2026 12:25 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646054798","title":"ARS Pharma Tumbles as Allergy Nasal Spray Faces Insurance Coverage Hurdle","url":"https://stock-news.laohu8.com/highlight/detail?id=2646054798","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646054798?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:40","pubTimestamp":1782394819,"startTime":"0","endTime":"0","summary":"BUZZ-ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle** Shares of ARS PharmaceuticalsSPRY.Ofall 26% to $7.79, snapping a three-day gaining streak** ARS Pharmaceuticals said la","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4N42X1DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0061475181.USD","LU1059921491.USD","BK4581","BK4139","LU0208291251.USD","LU1571399168.USD","LU2125909593.SGD","LU1699723380.USD","LU1923622614.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0432979614.USD","LU2433249047.HKD","LU0320765489.SGD","LU0072461881.USD","BK4504","CVS","LU0006061336.USD","LU0162691827.USD","BK4550","LU0211331839.USD","IE00BSNM7G36.USD","LU0070302665.USD","IE0002270589.USD","BK4196","LU2125909247.SGD","IE00B19Z3581.USD","BK4585","IE00B7SZLL34.SGD","SPRY","BK4588","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646287764","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2646287764","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646287764?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:40","pubTimestamp":1782387654,"startTime":"0","endTime":"0","summary":"Elme Communities  shares were down 23% in Thursday premarket activity after the company said in a regulatory filing that a buyer terminated its agreement to acquire the Riverside Apartments property in Alexandria, Virginia, ending the proposed $280 million transaction.ARS Pharmaceuticals  stock was down 20% after the company said no new commercial formulary additions or payer coverage decisions were issued for neffy in the July 1 cycle.Boxlight  shares were down 17%, following the previous session's 37% gain.Passage Bio  stock was down 17% after the company entered into a definitive all-stock merger agreement with biotechnology company Remix Therapeutics.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4565","PASG","ELME","SPRY","BK4170","BK4139","BOXL","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646844635","title":"Stocks to Watch: Micron, ARS Pharmaceuticals, Millerknoll, Passage Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2646844635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646844635?lang=en_us&edition=fundamental","pubTime":"2026-06-25 06:51","pubTimestamp":1782341460,"startTime":"0","endTime":"0","summary":"Micron Technology said revenue quadrupled in the second quarter and forecast that rapid growth will continue on strong demand for its memory chips. The company's results beat Wall Street expectations ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0157215616.USD","BK4579","LU1803068979.SGD","BK4575","LU2458330169.SGD","IE00BK4W5L77.USD","LU2360107168.USD","LU0889565833.HKD","LU1868836914.USD","BK4527","LU0127658192.USD","IE0002270589.USD","LU2250418816.HKD","LU2471134952.CNY","BK4139","IE00BK4W5M84.HKD","LU0109392836.USD","LU2290526834.HKD","LU1868836757.USD","LU0056508442.USD","IE0009356076.USD","LU1868836591.USD","LU0683600562.USD","BK4512","LU2089985449.USD","LU0061475181.USD","LU0096364046.USD","SG9999001424.SGD","LU2471134523.USD","MUD","BK4588","LU1914381329.SGD","LU2543165471.USD","IE000M9KFDE8.USD","LU1852331112.SGD","BK4553","LU0859254822.USD","LU0203347892.USD","LU2357627491.SGD","SPRY","MUU","IE00B5949003.HKD","LU0787776722.HKD","LU2054465674.USD","LU0154236417.USD","LU0719512351.SGD","LU1267930813.SGD","BK4605","LU0081259029.USD","MULL","LU0082616367.USD","LU2750360997.AUD","LU2750360641.GBP","LU1323610961.USD","BK4532","LU2471134879.HKD","MU","PASG","BK4143","BK4543","LU2458330243.SGD","LU1316542783.SGD","BK4533","LU2471134796.USD","LU1861215975.USD","LU0203345920.USD","LU2286300806.USD","LU2931357623.SGD","MLKN","LU0274383776.USD","GB00BDT5M118.USD","LU2211815571.USD","LU1861220033.SGD","BK4566","LU1366333091.USD","LU1868837136.USD","BK4141","LU1868837300.USD","IE00B19Z3B42.SGD","LU2360106780.USD","BK4554","LU2048586759.USD","BK4585","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0889566641.SGD","LU0792757196.USD","LU0642271901.SGD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646841288","title":"Shares of ARS Pharmaceuticals Fall After no New Commercial Insurers Add Neffy","url":"https://stock-news.laohu8.com/highlight/detail?id=2646841288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646841288?lang=en_us&edition=fundamental","pubTime":"2026-06-25 06:25","pubTimestamp":1782339900,"startTime":"0","endTime":"0","summary":"Shares of ARS Pharmaceuticals fell after the company said no commercial insurers had added its neffy nasal spray to their plans in the current insurance cycle.Shares plunged 23% to $8.12 in after-hours trading Wednesday. The stock closed up 2.5% at $10.54, down 9.5% this year.The company highlighted that neffy was added to Florida state Medicare coverage, but said there had been no commercial formulary additions or coverage decisions despite discussions with some payers stretching into mid-June.\"ARS Pharma intends to continue working with the remaining payers, and notes that neffy remains broadly accessible to commercially insured patients with the combination of direct coverage and a recently introduced retail cash option at a price consistent with other epinephrine products, the company said. \"Demand has continued to grow independent of additional coverage additions.\"The company cut its planned full-year cash-based operating expenses to around $248 million, citing cost discipline and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646454728","title":"ARS reports no new commercial formulary additions, coverage decisions for neffy","url":"https://stock-news.laohu8.com/highlight/detail?id=2646454728","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646454728?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:20","pubTimestamp":1782332429,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) provided an update on payer access for neffy epinephrine nasal spray and an updated financial outlook for 2026 and 2027....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ars-reports-no-new-commercial-formulary-additions-coverage-decisions-for-neffy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ars-reports-no-new-commercial-formulary-additions-coverage-decisions-for-neffy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646320845","title":"ARS Pharma Cuts 2026 Cash Operating Expense Outlook to $248 Million Excluding COGS","url":"https://stock-news.laohu8.com/highlight/detail?id=2646320845","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646320845?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:09","pubTimestamp":1782331771,"startTime":"0","endTime":"0","summary":"ARS Pharma cuts 2026 cash operating expense outlook to $248 million excluding COGSARS Pharmaceuticals cut its 2026 cash-based operating expense outlook, excluding COGS, to about USD 248 million on low","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDLbvNvzx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646845614","title":"ARS Pharmaceuticals Inc: Total 2026 Cash-based Operating Expenses, Excluding Cogs, Lowered to $248 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2646845614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646845614?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:05","pubTimestamp":1782331500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA8BZYJP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646685845","title":"ARS Pharmaceuticals Inc: Reaffirms Neffy Base Business Supports a Path to Cash-flow Breakeven in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2646685845","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646685845?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:05","pubTimestamp":1782331500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA8BZYJP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646456448","title":"ARS Pharmaceuticals - no New Commercial Formulary Additions for Neffy in July 1, 2026 Cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=2646456448","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646456448?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:05","pubTimestamp":1782331500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA8BZYJP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646072843","title":"ARS Pharmaceuticals Provides Commercial and Financial Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2646072843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646072843?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:05","pubTimestamp":1782331500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA8BZYJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643216316","title":"ARS Pharma Chief Commercial Officer Eric Karas sells 25,000 shares for $250,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2643216316","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643216316?lang=en_us&edition=fundamental","pubTime":"2026-06-13 08:06","pubTimestamp":1781309215,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Chief Commercial Officer Eric Karas exercised options for 25,000 common shares at USD 1.5 on June 12, 2026.Karas sold 25,000 common shares at USD 10 on June 12, 2026.Directly held common shares fell to 12,176 following the transactions.Directly held stock options rose to 519,588 following the exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDL9H3s90:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643216313","title":"ARS Pharma Chief Legal Officer Alexander Fitzpatrick sells 3,355 shares for $33,550","url":"https://stock-news.laohu8.com/highlight/detail?id=2643216313","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643216313?lang=en_us&edition=fundamental","pubTime":"2026-06-13 08:05","pubTimestamp":1781309118,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Chief Legal Officer Alexander A. Fitzpatrick sold 3,355 common shares on June 12, 2026 at USD 10.Fitzpatrick’s post-transaction stake totaled 90,910 common shares, held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDLbmY3Vt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ARS Pharma Chief Legal Officer Alexander Fitzpatrick sells 3,355 shares for $33,550","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640152461","title":"Drew Brees Collaborates With ARS Pharmaceuticals to Raise Awareness About Living Life With Severe Allergies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640152461","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640152461?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:00","pubTimestamp":1780574404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA7VT5QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ars-pharma.com","stockEarnings":[{"period":"1week","weight":-0.0794},{"period":"1month","weight":-0.1626},{"period":"3month","weight":-0.0211},{"period":"6month","weight":-0.3966},{"period":"1year","weight":-0.5598},{"period":"ytd","weight":-0.3236}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis. The company was founded in 2015 and is based in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.048654},{"month":2,"riseRate":0.5,"avgChangeRate":0.059864},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.043227},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.065084},{"month":5,"riseRate":0.833333,"avgChangeRate":0.033934},{"month":6,"riseRate":0.5,"avgChangeRate":0.05839},{"month":7,"riseRate":0.666667,"avgChangeRate":0.094753},{"month":8,"riseRate":0.4,"avgChangeRate":-0.080641},{"month":9,"riseRate":0.2,"avgChangeRate":-0.212128},{"month":10,"riseRate":0.4,"avgChangeRate":-0.021216},{"month":11,"riseRate":0.4,"avgChangeRate":0.043601},{"month":12,"riseRate":0.6,"avgChangeRate":0.080317}],"exchange":"NASDAQ","name":"ARS PHARMACEUTICALS INC","nameEN":"ARS PHARMACEUTICALS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARS PHARMACEUTICALS INC(SPRY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ARS PHARMACEUTICALS INC(SPRY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ARS PHARMACEUTICALS INC,SPRY,ARS PHARMACEUTICALS INC股票,ARS PHARMACEUTICALS INC股票老虎,ARS PHARMACEUTICALS INC股票老虎国际,ARS PHARMACEUTICALS INC行情,ARS PHARMACEUTICALS INC股票行情,ARS PHARMACEUTICALS INC股价,ARS PHARMACEUTICALS INC股市,ARS PHARMACEUTICALS INC股票价格,ARS PHARMACEUTICALS INC股票交易,ARS PHARMACEUTICALS INC股票购买,ARS PHARMACEUTICALS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARS PHARMACEUTICALS INC(SPRY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ARS PHARMACEUTICALS INC(SPRY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}